drugset / Trial / NCT01531205
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to test whether adding chemotherapy/cabazitaxel and hormonal/androgen deprivation therapy before surgical removal of your prostate would improve the outcome of salvage surgery for locally recurrent prostate cancer after the initial primary radiation therapy.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-09
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabazitaxel | Other / unclassified | 25 mg/m2 | Intravenous |
| Background | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Background | Goserelin | Other / unclassified | — | — |
| Background | Leuprolide | Other / unclassified | — | — |